Clinical Trial Update: A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects [Phase 1, Phase 2]

View source ↗

Summary

The study evaluated repeat-dose subcutaneous darbepoetin alfa in subjects with congestive heart failure and anemia, plus a single-dose control in healthy age- a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Heart Failure

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anemia, Congestive Heart Failure | Phase 1, Phase 2 | Status: COMPLETED